Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis

Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis

Bibliographic Details
Main Authors:	Jyotsna Ghosh, Sam Kant, Isabel Villegas Kastner, Duvuru Geetha
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921016004

Similar Items

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
by: Zdenka Hruskova, et al.
Published: (2020-02-01)

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
by: Lauren Floyd, et al.
Published: (2022-03-01)

Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology
by: Tessa K. Novick, et al.
Published: (2018-05-01)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
by: Mukhtyar, C, et al.
Published: (2006)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
by: E. N. Vorkel, et al.
Published: (2024-08-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
by: E. N. Vorkel, et al.
Published: (2024-12-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
by: Megan M. Sullivan, et al.
Published: (2024-01-01)

Clinical Presentation and Treatment Outcomes of Renal Medullary Angiitis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Center Case Series
by: Grant Kirby, et al.
Published: (2024-07-01)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
by: Morishita, K, et al.
Published: (2017)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
by: Mukhtyar, C, et al.
Published: (2008)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
by: Saket Jha, et al.
Published: (2019-01-01)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
by: Katarzyna Wawrzycka-Adamczyk, et al.
Published: (2024-08-01)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
by: Deep Shikha, et al.
Published: (2015-01-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
by: Sunil Kapur, et al.
Published: (2021-01-01)

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
by: Durga Prasanna Misra, et al.
Published: (2019-01-01)

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
by: Weiwei Hao, et al.
Published: (2024-07-01)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
by: Noah Huizenga, et al.
Published: (2020-04-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
by: T V Beketova
Published: (2018-05-01)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
by: Weiran Li, et al.
Published: (2021-03-01)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
by: Yoon Kook Kim, MD, et al.
Published: (2021-02-01)

A Tangled Autoimmune Trio: Multiple Sclerosis, Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antineutrophil Cytoplasmic Antibody Vasculitis
by: Rajaie Namas, et al.
Published: (2023-10-01)

Response to Vaccination Against SARS-CoV-2 in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Involvement
by: Jack E. Carruthers, et al.
Published: (2022-01-01)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
by: Flossmann, O, et al.
Published: (2006)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
by: Talks, S, et al.
Published: (1994)

Antineutrophil Cytoplasmic Antibody Vasculitis after Coronary Artery Bypass Grafting
by: Dwight D. Harris, et al.
Published: (2024-01-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
by: B N Shiva Prasad, et al.
Published: (2021-01-01)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
by: O. N. Egorova, et al.
Published: (2024-10-01)

The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
by: Kunal Chandwar, et al.
Published: (2022-01-01)

Antineutrophil cytoplasmic antibody vasculitis causing skull base inflammation and aortitis
by: Boby Varkey Maramattom, et al.
Published: (2018-01-01)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
by: Jamie R. Felzer, et al.
Published: (2022-01-01)

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China
by: Xiang-Yu Han, et al.
Published: (2024-05-01)

Treatment of severe perinuclear antineutrophil cytoplasmic antibody–associated vasculitis with efgartigimod
by: Afsoon Ghafari-Saravi, BS, et al.
Published: (2024-05-01)

Antineutrophil cytoplasmic antibodies
by: G.D. Sebastiani
Published: (2011-06-01)

Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis.
by: Marie Rimbert, et al.
Published: (2011-04-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis
by: Chand, S, et al.
Published: (2013)

Cardiovascular disease and antineutrophil cytoplasmic antibodies-associated vasculitis: A systematic review
by: Amal H. Mohamed, et al.
Published: (2024-08-01)

Frailty and antineutrophil cytoplasmic antibody‐associated vasculitis: What do we know?
by: Henry H. L. Wu, et al.
Published: (2023-12-01)

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement
by: Albert Hing Wong, et al.
Published: (2022-06-01)

Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
by: Jung Yoon Pyo, et al.
Published: (2022-12-01)

Acute respiratory failure as primary manifestation of antineutrophil cytoplasmic antibodies-associated vasculitis
by: Evdokia Sourla, et al.
Published: (2014-07-01)